Reoptimization for Great Power Competition

“I’m extremely proud of the Space Force and all the good it has accomplished. But, as good as we are, as much as we’ve done, as far as we’ve come, it’s not enough. We are not yet optimized for Great Power Competition.”

~ Chief of Space Operations
Gen. Chance Saltzman

The establishment of the U.S. Space Force was a direct response to threats arising from Great Power Competition in the space domain. Nevertheless, our legacy roots leave us sub-optimized for the security environment confronting us today, and we must finish fine-tuning the service to continue meeting its National Defense Strategy responsibilities

In early 2024, the Department of the Air Force unveiled sweeping plans for reshaping, refocusing, and reoptimizing the Air Force and Space Force to ensure continued supremacy in their respective domains while better posturing the services to deter and, if necessary, prevail in an era of Great Power Competition. Through a series of 24 DAF-wide key decisions, four core areas which demand the Department’s attention will be addressed: Develop People, Generate Readiness, Project Power and Develop Capabilities.

The space domain is no longer benign; it has rapidly become congested and contested.

We must enhance our capabilities, develop Guardians for modern warfare, prepare for the high intensity fight, and strengthen our power projection to thrive and win in this new era of Great Power Competition.

Video by Courtesy

RV144 10th Anniversary

Walter Reed Army Institute of Research

Nov. 26, 2019 | 6:00

WRAIR’s Military HIV Research Program headed the RV144 “Thai study,” the first-ever – and only to-date – clinical trial to demonstrate an HIV vaccine regimen was safe and modestly effective in preventing HIV infection. The RV144 trial represented a massive undertaking for the Army and serves as a model of international and interagency collaboration.

The trial involved more than 16,000 adult volunteers and a large network of partners who still collaborate with WRAIR today, including the Thai Ministry of Public Health, the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, and Sanofi Pasteur.

In Fall 2009 the Army announced that the investigational prime-boost vaccine regimen lowered the rate of HIV infection by 31.2 percent. These results, though modest, gave the global community hope that a vaccine to prevent HIV infection is possible at a time when such an achievement seemed elusive.